Schlender J, Teutonico D, Coboeken K, Schnizler K, Eissing T, Willmann S
Clin Pharmacokinet. 2018; 57(12):1613-1634.
PMID: 29737457
PMC: 6267540.
DOI: 10.1007/s40262-018-0661-6.
Navid A, Ng D, Wong S, Lightstone F
CPT Pharmacometrics Syst Pharmacol. 2016; 5(2):74-81.
PMID: 26933518
PMC: 4761233.
DOI: 10.1002/psp4.12061.
OBrien D, Friedman N, Cowan R, Pollard J, McDonald A, Callan P
PLoS Negl Trop Dis. 2015; 9(12):e0004253.
PMID: 26630648
PMC: 4667883.
DOI: 10.1371/journal.pntd.0004253.
Kiang T, Ensom M
Clin Pharmacokinet. 2015; 55(3):313-58.
PMID: 26346776
DOI: 10.1007/s40262-015-0321-z.
Sanchez Navarro M, Coloma Milano C, Zarzuelo Castaneda A, Sayalero Marinero M
Clin Pharmacokinet. 2002; 41(14):1213-20.
PMID: 12405867
DOI: 10.2165/00003088-200241140-00005.
Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
Kozawa O, Uematsu T, Matsuno H, Niwa M, Nagashima S, Kanamaru M
Antimicrob Agents Chemother. 1996; 40(12):2824-8.
PMID: 9124849
PMC: 163630.
DOI: 10.1128/AAC.40.12.2824.
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
Forrest A, Ballow C, Nix D, Birmingham M, Schentag J
Antimicrob Agents Chemother. 1993; 37(5):1065-72.
PMID: 8517693
PMC: 187899.
DOI: 10.1128/AAC.37.5.1065.
Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.
Wiseman L, Balfour J
Drugs Aging. 1994; 4(2):145-73.
PMID: 8186542
DOI: 10.2165/00002512-199404020-00007.
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.
Shah A, Lettieri J, Nix D, Wilton J, Heller A
Antimicrob Agents Chemother. 1995; 39(4):1003-6.
PMID: 7785969
PMC: 162672.
DOI: 10.1128/AAC.39.4.1003.
Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.
Golper T, Hartstein A, Morthland V, Christensen J
Antimicrob Agents Chemother. 1987; 31(11):1787-90.
PMID: 3435126
PMC: 175040.
DOI: 10.1128/AAC.31.11.1787.
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Monk J, Price A, Benfield P, Todd P, Ward A
Drugs. 1988; 35(4):373-447.
PMID: 3292209
DOI: 10.2165/00003495-198835040-00003.
Fluoroquinolone antimicrobial agents.
Wolfson J, Hooper D
Clin Microbiol Rev. 1989; 2(4):378-424.
PMID: 2680058
PMC: 358131.
DOI: 10.1128/CMR.2.4.378.
Serum levels of ciprofloxacin after single oral doses in patients with septicemia.
DEspine M, Bellido F, Pechere J, Auckenthaler R, Rohner P, Lew D
Eur J Clin Microbiol Infect Dis. 1989; 8(12):1019-23.
PMID: 2620671
DOI: 10.1007/BF01975162.
Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.
Hirata C, Guay D, Awni W, Stein D, Peterson P
Antimicrob Agents Chemother. 1989; 33(11):1927-31.
PMID: 2610503
PMC: 172789.
DOI: 10.1128/AAC.33.11.1927.
Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
Ljungberg B
Eur J Clin Microbiol Infect Dis. 1989; 8(6):515-20.
PMID: 2504591
DOI: 10.1007/BF01967470.
Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Stroshane R, Silverman M, Sauerschell R, Brown R, Boddy A, Cook J
Antimicrob Agents Chemother. 1990; 34(5):751-4.
PMID: 2360815
PMC: 171685.
DOI: 10.1128/AAC.34.5.751.
Clinical pharmacokinetics of ciprofloxacin.
Guay D, Rotschafer J
Clin Pharmacokinet. 1990; 19(6):434-61.
PMID: 2292168
DOI: 10.2165/00003088-199019060-00003.
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
Marchbanks C, Mikolich D, Mayer K, Zinner S, Dudley M
Antimicrob Agents Chemother. 1990; 34(10):1966-72.
PMID: 2291662
PMC: 171973.
DOI: 10.1128/AAC.34.10.1966.
Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
Taburet A, Devillers A, Thomare P, Fillastre J, Veyssier P, Singlas E
Clin Pharmacokinet. 1990; 19(1):80-8.
PMID: 2116257
DOI: 10.2165/00003088-199019010-00006.
Influence of subject age on the inhibition of oxidative metabolism by ciprofloxacin.
Waite N, Rybak M, Krakovsky D, Steinberg J, Warbasse L, Edwards D
Antimicrob Agents Chemother. 1991; 35(1):130-4.
PMID: 2014968
PMC: 244953.
DOI: 10.1128/AAC.35.1.130.